1. A Phase 1, Randomized, Placebo‐ and Active‐Controlled Crossover Study to Determine the Effect of Single‐Dose Ertugliflozin on QTc Interval in Healthy Volunteers. Issue 5 (18th January 2018) Authors: Sahasrabudhe, Vaishali; Saur, Didier; Matschke, Kyle; Terra, Steven G.; Hickman, Anne; Huyghe, Isabelle; Shi, Haihong; Cutler, David L. Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 5(2018) Page Start: 513 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Absolute Bioavailability of Bosutinib in Healthy Subjects From an Open‐Label, Randomized, 2‐Period Crossover Study. Issue 4 (23rd October 2017) Authors: Hsyu, Poe‐Hirr; Pignataro, Daniela Soriano; Matschke, Kyle Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 4(2018) Page Start: 373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abuse potential study of intravenous oxycodone hydrochloride alone or in combination with intravenous naltrexone in nondependent, recreational opioid users. (1st January 2015) Authors: Setnik, Beatrice; Bass, Almasa; Sommerville, Kenneth W.; Matschke, Kyle; Webster, Lynn R. Journal: Drug and alcohol dependence Issue: Volume 146(2015) Page Start: e94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Bioequivalence of Ertugliflozin/Sitagliptin Fixed‐Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components. Issue 7 (20th June 2019) Authors: Fediuk, Daryl J.; Matschke, Kyle; Liang, Yali; Pelletier, Kathleen B.; Wei, Hua; Shi, Haihong; Bass, Almasa; Hickman, Anne; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 7(2019) Page Start: 884 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed‐Dose Combination Tablets to Canadian‐Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States. Issue 5 (2nd November 2020) Authors: Dawra, Vikas Kumar; Pelletier, Kathleen; Matschke, Kyle; Shi, Haihong; Hickman, Anne; Zhou, Susan; Krishna, Rajesh; Sahasrabudhe, Vaishali Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 5(2021) Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effect of Food on the Pharmacokinetics of Ertugliflozin and Its Fixed‐Dose Combinations Ertugliflozin/Sitagliptin and Ertugliflozin/Metformin. Issue 5 (14th November 2018) Authors: Sahasrabudhe, Vaishali; Fediuk, Daryl J.; Matschke, Kyle; Shi, Haihong; Liang, Yali; Hickman, Anne; Bass, Almasa; Terra, Steven G.; Zhou, Susan; Krishna, Rajesh; Dawra, Vikas K. Journal: Clinical pharmacology in drug development Issue: Volume 8:Issue 5(2019) Page Start: 619 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO‐02, an extended release formulation of oxycodone with sequestered naltrexone. Issue 5 (22nd January 2015) Authors: Gandelman, Kuan; Lamson, Michael; Salageanu, Joanne; Bramson, Candace; Matschke, Kyle; Malhotra, Bimal Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 5(2015:Sep./Oct.) Page Start: 370 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects. Issue 2 (22nd October 2013) Authors: Korth‐Bradley, Joan M.; Parks, Virginia; Wagner, Frank; Chalon, Stephan; Gourley, Ian; Matschke, Kyle; Gossart, Sophie; Ripp, Sharon L.; Fleckenstein, Lawrence Journal: Clinical pharmacology in drug development Issue: Volume 3:Issue 2(2014:Mar./Apr.) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Evaluation of Proton Pump Inhibitor Esomeprazole on Crizotinib Pharmacokinetics in Healthy Participants. Issue 1 (26th November 2021) Authors: Xu, Huiping; O'Gorman, Melissa; Matschke, Kyle; Boutros, Tanya; Brega, Nicoletta; Tan, Weiwei; Bello, Akintunde Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 1(2022) Page Start: 34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Intranasal administration of crushed ALO‐02 (extended‐release oxycodone with sequestered naltrexone): A randomized, controlled abuse‐potential study in nondependent recreational opioid users. (2nd July 2015) Authors: Setnik, Beatrice; Bramson, Candace; Bass, Almasa; Levy‐Cooperman, Naama; Malhotra, Bimal; Matschke, Kyle; Sommerville, Kenneth W.; Wolfram, Gernot; Geoffroy, Pierre Journal: Journal of clinical pharmacology Issue: Volume 55:Number 12(2015:Dec.) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗